Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
In an effort to understand the ongoing physician burnout crisis, Lightning Bolt Solutions, a company that offers AI-based, physician shift scheduling technology, is attempting to study one million physician shift hours.
Researchers at the University of Southern California Viterbi School of Engineering have utilized machine learning to detect clusters of potential biomarkers of Alzheimer’s disease. This will allow for earlier diagnosis and could potentially lead to non-invasive methods of tracking the progression of the disease in impacted patients. Findings were published in the journalFrontiers in Aging NeuroScience.
Anthem, the nation’s second-largest health insurer, is planning to push up the launch date of its new pharmacy benefit manager (PBM) business, the company announced during its end-of-year earnings report.
British clinical AI company Sensyne Health and the University of Oxford’s Big Data Institute are partnering to establish a research alliance focused on using AI and digital technology to better understand chronic diseases.
Using an AI-based method, researchers at Cardiff University in Cardiff, Wales, developed a clinical prediction model, according to a study published in PLOS One. The model showed it can provide an accurate and reliable prognosis for patients with cardiovascular disease when compared to traditional methods.
